These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29303152)

  • 21. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
    Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eplerenone for treatment of chronic central serous chorioretinopathy.
    Fraenkel D; Suffo S; Langenbucher A; Seitz B; Abdin AD
    Eur J Ophthalmol; 2021 Jul; 31(4):1885-1891. PubMed ID: 32854564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS: A ONE-YEAR PILOT STUDY.
    Ghadiali Q; Jung JJ; Yu S; Patel SN; Yannuzzi LA
    Retina; 2016 Mar; 36(3):611-8. PubMed ID: 26405766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
    van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Mineralocorticoid-Receptor Antagonists: Choroidal Parameters Changes Using OCT in Central Serous Chorioretinopathy.
    Faghihi H; Mohammadzadeh V; Nabavi A; Faghihi S; Kadivar S; Ghassemi F
    Ophthalmic Surg Lasers Imaging Retina; 2019 Nov; 50(11):726-733. PubMed ID: 31755972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR).
    Rahimy E; Pitcher JD; Hsu J; Adam MK; Shahlaee A; Samara WA; Vander JF; Kaiser RS; Chiang A; Spirn MJ; Fineman MS
    Retina; 2018 May; 38(5):962-969. PubMed ID: 28426624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual vs. combined imaging modalities for diagnosing neovascular central serous chorioretinopathy.
    Borrelli E; Viganò C; Battista M; Sacconi R; Senni C; Querques L; Grosso D; Bandello F; Querques G
    Graefes Arch Clin Exp Ophthalmol; 2023 May; 261(5):1267-1273. PubMed ID: 36441229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical Coherence Tomography Angiography Compared with Multimodal Imaging for Diagnosing Neovascular Central Serous Chorioretinopathy.
    Ng DS; Ho M; Chen LJ; Yip FL; Teh WM; Zhou L; Mohamed S; Tsang CW; Brelén ME; Chen H; Pang CP; Lai TYY
    Am J Ophthalmol; 2021 Dec; 232():70-82. PubMed ID: 34116008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy].
    Li L; Li DH; Yang ZK; Bian AL; Chen YX; Dong FT
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):878-82. PubMed ID: 23302240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal assessment of patients with chronic central serous chorioretinopathy.
    Viana KÍS; Leão PMS; Fernandes L; Siqueira R; Ribeiro J; Jorge R
    Arq Bras Oftalmol; 2017 Jun; 80(3):181-185. PubMed ID: 28832738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: Preliminary results.
    Demircan A; Yesilkaya C; Alkin Z
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():375-378. PubMed ID: 29409857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial.
    Willcox A; Culliford L; Ellis L; Rogers CA; Cree A; Chakravarthy U; Ennis S; Behar-Cohen F; Reeves BC; Sivaprasad S; Lotery A
    Eye (Lond); 2019 Feb; 33(2):295-303. PubMed ID: 30194380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choroidal Neovascularisation Complicating Chronic Central Serous Chorioretinopathy: The Discovery Rate on Multimodal Imaging.
    Romdhane K; Mantel I
    Klin Monbl Augenheilkd; 2019 Apr; 236(4):536-541. PubMed ID: 30999331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.
    Dhurandhar DS; Singh SR; Sahoo NK; Goud A; Lupidi M; Chhablani J
    Br J Ophthalmol; 2020 Jul; 104(7):904-909. PubMed ID: 31563867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy.
    Pichi F; Carrai P; Ciardella A; Behar-Cohen F; Nucci P;
    Int Ophthalmol; 2017 Oct; 37(5):1115-1125. PubMed ID: 27757733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OCT Angiography Findings in Acute Central Serous Chorioretinopathy.
    Feucht N; Maier M; Lohmann CP; Reznicek L
    Ophthalmic Surg Lasers Imaging Retina; 2016 Apr; 47(4):322-7. PubMed ID: 27065370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the Etiology of Central Serous Chorioretinopathy Using En-Face Optical Coherence Tomography and Indocyanine Green Angiography.
    Shinojima A; Fujita K; Mori R; Kawamura A; Yuzawa M; Yasukawa T
    Ophthalmologica; 2016; 236(2):100-7. PubMed ID: 27532435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.
    van Rijssen TJ; van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1395-1402. PubMed ID: 29732468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].
    Liu Y; Li L; Xu G; Wang W
    Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):328-34. PubMed ID: 27220704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series.
    Salz DA; Pitcher JD; Hsu J; Regillo CD; Fineman MS; Elliott KS; Vander JF; Fischer DH; Spirn MJ
    Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):439-44. PubMed ID: 25970864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.